← Back to Screener
YD Bio Limited Warrants (YDESW)
Price$0.46
Favorite Metrics
Price vs S&P 500 (26W)-85.39%
Price vs S&P 500 (4W)-35.24%
All Metrics
Price vs S&P 500 (YTD)-52.11%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.01M
52-Week High$2.85
26-Week Price Return-76.64%
13-Week Price Return-56.74%
3-Month Return Std Dev113.53%
Year-to-Date Return-49.75%
5-Day Price Return-2.43%
Month-to-Date Return-23.45%
Price vs S&P 500 (13W)-59.60%
Beta1.40x
52-Week Low$0.17
Industry Peers — Health Services(21)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
YDESWYD Bio Limited Warrants | — | — | — | — | $0.46 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $207.74 |
LHLabcorp Holdings Inc. | 25.31x | 7.25% | 9.92% | 10.28% | $269.19 |
DGXQuest Diagnostics Inc. | 21.75x | 11.78% | 14.10% | 13.88% | $196.31 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $91.07 |
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $57.85 |
VCYTVeracyte, Inc. | 39.66x | 16.01% | 11.17% | 5.33% | $33.45 |
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $51.20 |
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $21.29 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.44 |
About
YD Bio Ltd is a biopharmaceutical company developing diagnostic and therapeutic solutions, including blood-based cancer detection tests and stem cell- and exosome-based therapeutics for diseases with significant unmet medical needs. The company also supplies clinical testing drugs to pharmaceutical companies.